AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Penumbra, Inc.
XNYS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001TRHPB0
324.39▼ 0.57 (-0.18%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
324.96
Day's Range
323.88 – 325.33
52-Week Range
221.26 – 362.46
Volume
357.9K
Avg Volume
388.4K
Share Statistics
Shares Outstanding
Employees
4,700
Exchange
XNYS
Listed
2015-09-18
Share count as of July 14, 2026

Penumbra, Inc. (PEN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Penumbra, Inc. (PEN)
What is Penumbra, Inc.'s Market Cap?
Penumbra, Inc.'s Market Cap is $12.8B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Enterprise Value?
Penumbra, Inc.'s Enterprise Value is $12.6B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Trailing P/E?
Penumbra, Inc.'s Trailing P/E is 79.6×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Price / Sales?
Penumbra, Inc.'s Price / Sales is 8.5×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EV / Revenue?
Penumbra, Inc.'s EV / Revenue is 8.4×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EV / EBITDA?
Penumbra, Inc.'s EV / EBITDA is 61.6×, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Revenue (TTM)?
Penumbra, Inc.'s Revenue (TTM) is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Net Income (TTM)?
Penumbra, Inc.'s Net Income (TTM) is $160.6M, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s EBITDA?
Penumbra, Inc.'s EBITDA is $204.5M, based on as-reported figures from SEC (XBRL) filings.
What is Penumbra, Inc.'s Diluted EPS (TTM)?
Penumbra, Inc.'s Diluted EPS (TTM) is 4.08, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PENAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+14.9%+15.6%+22.1%+17.8%
Cost of revenue
Gross profit
% of revenue67.9%67.6%68.0%67.8%
Operating expenses:
Research and development
Sales, general and administrative
Total operating expenses
% of revenue57.4%57.4%52.6%54.0%
Income from operations
% of revenue10.5%10.2%15.4%13.8%
Interest and other income, net—
Income before income taxes
Provision for income taxes
Net income
% of revenue8.9%8.7%12.3%12.9%
Basic (in dollars per share)
Diluted (in dollars per share)